Letter to HKAB: Deemed comparable jurisdictions under SPM CR-G-14 (2026-06-08)

Supervisory Policy Manual Email: HKMA E-mail Alert of 09 June 2026 (05:00 p.m. HKT)

Document Information

Title: Letter to HKAB: Deemed comparable jurisdictions under SPM CR-G-14 (2026-06-08)

Type: Supervisory Policy Manual

URL: https://brdr.hkma.gov.hk/eng/doc-ldg/current/20260605-10-EN

Email Received: 2026-06-09 17:20

Summary Created: 2026-06-09 12:00

English Summary
Quick section switch
Management Summary
  • Purpose / Background: The HKMA is proposing an update to SPM module CR-G-14 regarding the identification of "deemed comparable" jurisdictions for non-centrally cleared OTC derivatives margin requirements, as the current 2020 references have become outdated.
  • One-line conclusion: The HKMA proposes replacing the existing "WGMR member" reference with "BCBS member jurisdictions" to maintain alignment with current global standards.
  • Key Changes:
  • Shift from WGMR member jurisdictions to BCBS member jurisdictions as the benchmark for "deemed comparable" status under paragraph 2.3.2.
  • Reference points for AIs updated to the BIS website for membership status and the BCBS Basel III implementation dashboard for monitoring compliance progress.
  • Future-proofing the SPM to ensure criteria remain dynamic as Basel Committee membership evolves.
  • Key Dates / Deadlines:
  • 30 June 2026: Deadline for HKAB to submit comments on the proposed amendment.
  • Second half of 2026: Planned industry consultation for the broader revised SPM CR-G-14 module.
  • Applicability / Impact scope: All Authorized Institutions (AIs) conducting non-centrally cleared OTC derivatives transactions that rely on jurisdictional comparability for margin and risk mitigation requirements.
  • Recommended management actions:
  • Review internal policy frameworks that currently map against "WGMR member" lists to assess the impact of a switch to "BCBS member" lists.
  • Provide feedback to the HKAB by the 30 June 2026 deadline if the transition to BCBS membership creates specific operational or compliance conflicts.
  • Prepare for a comprehensive review of internal margin protocols in anticipation of the broader SPM CR-G-14 update later this year.
Detailed Summary
  1. Document overview
  • Nature: Regulatory consultation letter regarding technical amendments to SPM CR-G-14.
  • Purpose: To modernize the definition of "deemed comparable jurisdictions" used for margin and risk mitigation standards in non-centrally cleared OTC derivatives.
  • Scope: Applies to all AIs subject to SPM CR-G-14.
  1. Main requirements
  • Current status: The current SPM references WGMR members in footnote 27 of paragraph 2.3.2.
  • Proposed requirement: Replace current references with "BCBS member jurisdictions."
  • Verification: AIs are directed to use the BIS website for current BCBS membership and the Basel III implementation dashboard to verify the specific status of margin requirements in those jurisdictions.
  1. Key changes
  • Transition from a WGMR-based definition to a BCBS-based definition.
  • Improved reliance on official, up-to-date BIS monitoring tools rather than static list references within the SPM text.
  1. Important dates & transition
  • 30 June 2026: Consultation feedback due to HKMA.
  • H2 2026: Upcoming release of a fully revised SPM CR-G-14 for industry consultation.
  1. Impact and risks
  • Compliance Risk: AIs must ensure their internal "comparable jurisdiction" lists are updated to align with the proposed BCBS membership criteria.
  • Operational Risk: Potential impact on collateral management systems if the change in jurisdiction lists affects the eligibility or treatment of counterparties in non-centrally cleared trades.
  1. Compliance action checklist
  • [ ] Conduct internal impact assessment of the switch from WGMR to BCBS criteria.
  • [ ] Review current list of counterparties/jurisdictions currently categorized as "deemed comparable."
  • [ ] Submit industry comments via HKAB before the 30 June 2026 deadline.
  • [ ] Monitor the HKMA website for the upcoming full consultation of SPM CR-G-14 in H2 2026.
  1. Appendices/attachments summary
  • There are no formal appendices attached to this letter; however, the text references two external URLs (BIS membership and Basel III implementation dashboard) which serve as the definitive source for regulatory compliance under the proposed change.
中文摘要
快速切換摘要區塊
管理層摘要
  • 目的/背景 針對《監管政策手冊》(SPM)CR-G-14「非中央結算場外衍生工具交易-保證金及其他風險緩釋標準」,因應業界查詢,金管局擬更新其中有關「視同可比司法管轄區(Deemed comparable jurisdictions)」的認定標準。
  • 一句話結論 金管局計劃將 SPM CR-G-14 第 2.3.2 段中,認定為「視同可比」的司法管轄區範圍,由原先的「WGMR 會員」調整為「巴塞爾銀行監管委員會(BCBS)會員」。
  • 關鍵變更
  1. 修改認定標準: 明確改以 BCBS 會員資格作為判斷基準。
  2. 效力追溯: 凡納入 BCBS 會員之司法管轄區,其保證金及風險緩釋標準自該國相關規定生效日起,即被視為具備可比性。
  3. 參考來源更新: 機構應直接參閱國際結算銀行(BIS)網站的 BCBS 會員清單,以及 Basel III 實施監控儀表板來確認實施狀態。
  • 重要日期
  • 業界意見徵詢截止日: 2026 年 6 月 30 日。
  • 全面修訂計畫: 金管局預計於 2026 年下半年就整份 SPM CR-G-14 進行正式諮詢。
  • 適用對象 / 影響範圍 所有從事非中央結算場外衍生工具交易的認可機構(AIs)。
  • 管理層建議行動
  1. 評估現有交易對手方是否依賴舊有的 WGMR 司法管轄區認定,並預先分析改用 BCBS 標準後的合規影響。
  2. 若貴行對此修訂有任何運作上的疑慮或建議,請務必於 2026 年 6 月 30 日前通過香港銀行公會提交意見。
  3. 密切關注 2026 年下半年關於 SPM CR-G-14 的全面修訂諮詢文件。
詳細摘要

1) 文檔概述
本文檔為金管局致香港銀行公會(HKAB)的信函,旨在徵詢業界對於修訂 SPM CR-G-14 中「視同可比司法管轄區」認定準則的初步意見。此舉旨在回應近期業界對於該政策與國際實務一致性的詢問。

2) 主要要求

  • 認定準則調整 金管局擬將原本參照「WGMR 會員」的規定,正式調整為採用「BCBS 會員」司法管轄區作為基準。
  • 合規判定邏輯 一旦納入 BCBS 會員清單,該轄區的保證金及風險緩釋標準即被自動視為與香港要求具備可比性,無需額外逐項核對。
  • 資訊獲取義務 認可機構(AIs)須自行維護最新的 BCBS 會員狀態及 Basel III 實施進度監控,相關資訊來源如下:
  • [BCBS 會員名單](https: //www.bis.org/bcbs/membership.htm)
  • [Basel III 實施監控儀表板](https: //www.bis.org/bcbs/implementation/rcap_reports.htm)

3) 關鍵變更

  • 對比 2020 年版 SPM CR-G-14,原註腳 27 所引用的 WGMR 框架已不合時宜。本次修訂將認定機制掛鉤於較為廣泛且標準化的 BCBS 會員制度,旨在提供更明確的合規指引。

4) 重要日期與過渡安排

  • 意見反饋期 截至 2026 年 6 月 30 日。
  • 後續步驟 金管局正對 SPM CR-G-14 進行整體審查,預計於 2026 年下半年發布修訂草案供業界諮詢。

5) 對機構的影響與風險

  • 正面影響 提升判斷標準的透明度與客觀性,減少對「何謂可比」的歧義解釋。
  • 合規風險 若機構目前依賴的某個司法管轄區屬於 WGMR 但非 BCBS 成員,該轄區在新規實施後可能不再被視為「視同可比」,機構需監控相關司法管轄區的 BCBS 會籍變化。

6) 合規動作清單(Checklist)

  • [ ] 審核現行場外衍生工具業務中,涉及跨司法管轄區的保證金抵免是否依賴現行認定標準。
  • [ ] 檢查貴行內部的合規政策是否直接參照了舊版的 WGMR 註腳。
  • [ ] 參與 HKAB 的討論,並於 2026 年 6 月 30 日前提出貴行對修訂內容的技術性反饋。

7) 附件/附錄摘要

  • 本文件無額外附件(原文件為單一信函)。